ClinicalTrialsFinder

Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive Clinical Trials in Montreal, Quebec

1 recruitingMontreal, Quebec, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Novartis Pharmaceuticals50 enrolled4 locationsNCT07354074